A cyclic peptide that disrupts interaction between GluK2 (formally GluR6) and postsynaptic density protein 95 (PSD-95) through competing with the C terminal of GluK2 to bind the PDZ1 domain of PSD-95. It inhibits clustering of kainate receptors.
CAT# | R0842 |
CAS | 1315378-73-4 |
M.F/Formula | C38H61N9O11 |
M.W/Mr. | 819.95 |
Sequence | YKKTEAV (Modifications: Ala-6 = β-Ala, Cyclized = Lys-3 - Ala-6) |
Appearance | White lyophilised solid |
Purity | >98 % |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Angiotensin Ⅱ is a kind of peptides generally produced by the hydrolysis of the angiotensin Ⅰ under the angioten ...
Delcasertib, also known as KAI-9803, is a 23-amino acid peptide and δ-protein kinase C (δ-PKC) inhibitor. KAI-9 ...
Ecallantide, sold under the trade name Kalbitor, is a plasma kallikrein inhibitor, consisting of sixty amino aci ...
Nafarelin acetate is a gonadotropin-releasing hormone (GnRH) agonist which is as effective as danazol in the tre ...
JIP1, a member of the JIPs family, was first discovered to promote JNK activation by combining multiple componen ...